Market Cap ₹7 Cr.
Stock P/E 6.6
P/B 1.6
Current Price ₹8.6
Book Value ₹ 5.4
Face Value 10
52W High ₹18
Dividend Yield 0%
52W Low ₹ 6.9
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 14 | 4 | 12 | 7 | 4 | 1 | 11 | 5 | 34 | 34 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 14 | 4 | 12 | 7 | 4 | 1 | 11 | 5 | 34 | 34 |
Total Expenditure | 14 | 4 | 12 | 6 | 4 | 1 | 10 | 5 | 34 | 34 |
Operating Profit | 0 | -0 | -0 | 0 | 0 | -0 | 1 | 0 | 0 | 0 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | -0 | -0 | 0 | 0 | -0 | 1 | 0 | 0 | 0 |
Provision for Tax | 0 | -0 | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 |
Profit After Tax | 0 | -0 | -0 | 0 | 0 | -0 | 1 | 0 | 0 | -0 |
Adjustments | -0 | 0 | 0 | -0 | 0 | 0 | 0 | -0 | -0 | -0 |
Profit After Adjustments | 0 | -0 | -0 | 0 | 0 | -0 | 1 | 0 | 0 | -0 |
Adjusted Earnings Per Share | 0 | -0.4 | -0 | 0.5 | 0.1 | -0.4 | 0.9 | 0 | 0.5 | -0.1 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 0 | 0 | 0 | 0 | 1 | 100 | 144 | 31 | 34 | 37 | 37 | 84 |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Income | 0 | 0 | 0 | 0 | 1 | 100 | 144 | 31 | 34 | 37 | 37 | 84 |
Total Expenditure | 0 | 0 | 0 | 0 | 1 | 100 | 144 | 31 | 34 | 37 | 37 | 83 |
Operating Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 |
Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 |
Profit After Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 1 |
Adjusted Earnings Per Share | 0 | 0 | 0 | 0 | 0 | 0.3 | 0.2 | -0 | 0 | 0 | 0.1 | 1.3 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 0% | 6% | -18% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | NA% | 5% | -11% | NA% |
ROE Average | 2% | 1% | 2% | 1% |
ROCE Average | 3% | 1% | 2% | 2% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 |
Total Current Liabilities | 0 | 0 | 0 | 0 | 0 | 29 | 14 | 7 | 0 | 1 | 3 |
Total Liabilities | 4 | 4 | 4 | 4 | 4 | 33 | 18 | 11 | 10 | 5 | 7 |
Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 4 | 4 | 4 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 0 | 0 | 0 | 0 | 0 | 33 | 18 | 11 | 10 | 5 | 7 |
Total Assets | 4 | 4 | 4 | 4 | 4 | 33 | 18 | 11 | 10 | 5 | 7 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 1 |
Cash Flow from Operating Activities | 0 | 0 | 0 | -0 | -0 | 3 | -3 | 0 | -4 | 5 | 0 |
Cash Flow from Investing Activities | 0 | 0 | 0 | 0 | -0 | 1 | -0 | -0 | -0 | -0 | 0 |
Cash Flow from Financing Activities | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 5 | -5 | 0 |
Net Cash Inflow / Outflow | 0 | 0 | 0 | -0 | -0 | 3 | -3 | 0 | 0 | 0 | 0 |
Closing Cash & Cash Equivalent | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 1 | 1 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.25 | 0.2 | -0 | 0.02 | 0.04 | 0.1 |
CEPS(Rs) | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.25 | 0.25 | 0.05 | 0.05 | 0.06 | 0.11 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 4.31 | 4.32 | 4.33 | 4.34 | 4.34 | 4.59 | 4.8 | 4.8 | 4.82 | 4.86 | 4.96 |
Core EBITDA Margin(%) | 8.5 | 7.87 | 6.58 | 6.65 | 0.82 | 0.31 | 0.14 | 0.11 | 0.19 | 0.17 | 0.35 |
EBIT Margin(%) | 8.5 | 7.87 | 6.58 | 6.65 | 0.82 | 0.32 | 0.17 | 0 | 0.12 | 0.13 | 0.33 |
Pre Tax Margin(%) | 8.5 | 7.87 | 6.58 | 6.65 | 0.71 | 0.32 | 0.17 | -0 | 0.07 | 0.13 | 0.33 |
PAT Margin (%) | 6.92 | 6.41 | 4.55 | 4.59 | 0.49 | 0.22 | 0.12 | -0 | 0.05 | 0.1 | 0.24 |
Cash Profit Margin (%) | 6.92 | 6.41 | 4.55 | 4.59 | 0.49 | 0.22 | 0.15 | 0.14 | 0.12 | 0.13 | 0.26 |
ROA(%) | 0.22 | 0.24 | 0.2 | 0.22 | 0.06 | 1.19 | 0.7 | -0.01 | 0.17 | 0.49 | 1.44 |
ROE(%) | 0.23 | 0.25 | 0.2 | 0.22 | 0.07 | 5.66 | 4.36 | -0.03 | 0.42 | 0.86 | 2.03 |
ROCE(%) | 0.28 | 0.31 | 0.29 | 0.32 | 0.11 | 7.81 | 6.02 | 0.03 | 0.63 | 0.74 | 2.88 |
Receivable days | 0 | 0 | 32.76 | 60.58 | 31.5 | 49.43 | 52.76 | 141.51 | 64.38 | 21.42 | 32.09 |
Inventory Days | 0 | 0 | 0 | 0 | 0 | 6.08 | 5.25 | 22.58 | 38.26 | 42.56 | 16.46 |
Payable days | 0 | 0 | 0 | 0 | 0 | 53.01 | 54.28 | 122.82 | 37.27 | 5.31 | 16.53 |
PER(x) | 0 | 0 | 0 | 0 | 6534.48 | 40.46 | 62.49 | 0 | 0 | 0 | 0 |
Price/Book(x) | 0 | 0 | 0 | 0 | 4.37 | 2.23 | 2.66 | 0 | 0 | 0 | 0 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 70.09 | 59.56 | 51.99 | 47.5 | 33.32 | 0.06 | 0.08 | 0.28 | 0.38 | 0.22 | 0.21 |
EV/Core EBITDA(x) | 824.78 | 756.56 | 790.34 | 714.44 | 4044.71 | 17.31 | 38.81 | 187.87 | 201.31 | 129.42 | 59.55 |
Net Sales Growth(%) | 0 | 17.67 | 14.52 | 9.5 | 176.44 | 0 | 43.67 | -78.67 | 12.02 | 6.51 | 0.9 |
EBIT Growth(%) | 0 | 9.02 | -4.3 | 10.66 | -65.75 | 7539.34 | -22.79 | -99.41 | 2836.92 | 15.23 | 149.96 |
PAT Growth(%) | 0 | 9.02 | -18.82 | 10.66 | -70.41 | 8738.91 | -19.11 | -100.63 | 1670.02 | 107.4 | 138.7 |
EPS Growth(%) | 0 | 9.39 | -19.44 | 11.13 | -70.01 | 8618.78 | -19.12 | -100.63 | 1672.27 | 106.93 | 139 |
Debt/Equity(x) | 0 | 0 | 0 | 0 | 0.1 | 0 | 0 | 0.06 | 1.18 | 0 | 0 |
Current Ratio(x) | 0.29 | 0.23 | 0.37 | 0.52 | 8.97 | 1.14 | 1.29 | 1.64 | 21.28 | 5.07 | 2.7 |
Quick Ratio(x) | 0.29 | 0.23 | 0.37 | 0.52 | 8.97 | 1.08 | 1.12 | 1.45 | 8.18 | 2.48 | 2.43 |
Interest Cover(x) | 0 | 0 | 0 | 0 | 7.34 | 256.68 | 305.48 | 0.49 | 2.25 | 971.03 | 86.42 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.02 | 0 | 0 | 0 | 0 | 0 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 30.2 | 30.2 | 30.2 | 30.2 | 30.2 | 30.2 | 30.2 | 30.2 | 30.2 | 30.2 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 69.8 | 69.8 | 69.8 | 69.8 | 69.8 | 69.8 | 69.8 | 69.8 | 69.8 | 69.8 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 | 0.61 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About